Cargando…
Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs
OBJECTIVE: We performed a systematic review and meta-analysis for exploring clinical benefits and safety of tocilizumab in addition to standard of care (SOC) in treating patients with coronavirus disease 2019 (COVID-19). METHODS: An electronic search was carried out in PubMed, EMBASE, Cochrane Libra...
Autores principales: | Mutua, Victor, Henry, Brandon Michael, von Csefalvay, Chris, Cheruiyot, Isaac, Vikse, Jens, Lippi, Giuseppe, Bundi, Brian, Mong’are, Newnex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972884/ https://www.ncbi.nlm.nih.gov/pubmed/35315395 http://dx.doi.org/10.23750/abm.v93i1.12208 |
Ejemplares similares
-
The Unusual High Origin Radial Artery in a Black Kenyan Population: A Cadaveric Study
por: Bundi, Brian N, et al.
Publicado: (2022) -
Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020) -
Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19
por: Michael Henry, Brandon, et al.
Publicado: (2022) -
Acute kidney injury is associated with worse prognosis in COVID-19 patients: a systematic review and meta-analysis
por: Cheruiyot, Isaac, et al.
Publicado: (2020) -
Tocilizumab in COVID-19: Beware the risk of intestinal perforation
por: Vikse, Jens, et al.
Publicado: (2020)